Vanda Sues FDA Over Off-label Marketing

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Vanda Pharmaceuticals Challenges Constitutionality of FDA's Restrictions on Off-Label Marketing

J.W. Schomisch

April 15, 2025 at 10:14 AM EST

Vanda Pharmaceuticals Inc. wants a federal district court to remove the FDA’s restrictions on company marketing of off-label uses of agency-approved products. According to the lawsuit filed in the U.S. District Court for the Southern District of Texas, Vanda, along with a physician and patient, sued the FDA and the Department of Health and Human Services requesting a judgment... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Vanda Pharmaceuticals Challenges Constitutionality of FDA's Restrictions on Off-Label Marketing

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT